Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

53.84
-0.1000-0.19%
Post-market: 53.72-0.1200-0.22%18:55 EDT
Volume:3.03M
Turnover:164.53M
Market Cap:109.34B
PE:14.41
High:54.75
Open:54.23
Low:53.79
Close:53.94
52wk High:61.70
52wk Low:32.38
Shares:2.03B
Float Shares:1.95B
Volume Ratio:0.59
T/O Rate:0.16%
Dividend:1.75
Dividend Rate:3.25%
EPS(TTM):3.74
EPS(LYR):3.74
ROE:43.31%
ROA:9.79%
PB:5.04
PE(LYR):14.41

Loading ...

GlaxoSmithKline (GSK) Gets a Sell from J.P. Morgan

TIPRANKS
·
Jan 23

GSK Halts Early-Stage Sickle Cell Study, Tweaking the Risk Profile of Its Rare Disease Pipeline

TIPRANKS
·
Jan 23

Another "Miracle Drug" for Growth? Can "Northeast Pharma Darling" Replicate Its "Hormone Legend"?

Deep News
·
Jan 22

GSK and Alector Phase 3 Dementia Trial Ends Early: What Investors Need to Know

TIPRANKS
·
Jan 22

UBS Sticks to Its Hold Rating for GlaxoSmithKline (GSK)

TIPRANKS
·
Jan 21

PRESS DIGEST-British Business - January 21

Reuters
·
Jan 21

Top Midday Gainers

MT Newswires Live
·
Jan 21

Barclays Reaffirms Their Sell Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Jan 21

GSK, Shionogi reach agreement with Pfizer for interest in ViiV Healthcare

TIPRANKS
·
Jan 20

Top Premarket Gainers

MT Newswires Live
·
Jan 20

This Biotech Stock Surges 64%. The Big Pharma M&A Battle Is Heating Up. -- Barrons.com

Dow Jones
·
Jan 20

How Greenland could turn into a Big Tech problem, according to Morgan Stanley's Mike Wilson

Dow Jones
·
Jan 20

GSK's Tesaro Licenses Alteogen Enzyme Technology

MT Newswires Live
·
Jan 20

GSK to acquire US biotech group for $2.2bn

cityam
·
Jan 20

GSK to acquire Rapt Therapeutics for $58.00 per share

TIPRANKS
·
Jan 20

Why Rapt Therapeutics Shares Are Trading Higher By 63%; Here Are 20 Stocks Moving Premarket

Benzinga
·
Jan 20

Dow Jones Top Company Headlines at 3 AM ET: GSK to Acquire RAPT for $2.2 Billion to Bolster Food Allergy Treatments | Baidu's ...

Dow Jones
·
Jan 20

GSK to Buy RAPT Therapeutics in $2.2 Billion Deal for Promising Food Allergy Therapy

Reuters
·
Jan 20

GSK - Pfizer to Receive $1.875 Bn, GSK Special Dividend of $0.250 Bn

THOMSON REUTERS
·
Jan 20

GSK - Deal Completion Expected in Q1 2026, Subject to Regulatory Clearances

THOMSON REUTERS
·
Jan 20